1Vogelzang N J, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in pa- tients with malignant pleural mesothelioma [ J ]. Clin Oncol, 2003,21 (14) :2636-2644.
2Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy [ J ]. J Clin Oncol, 2004, 22(9) :1589-1597.
3Scagliottio GV, parikh P, yon Pawel J, et al. Phase 11I study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemother- apynaive patinents with advanced-stage non-small-cell lung cancer[ J ] J Clin Oncol,2005,21 (9) :1435-1427.
4Azzoli CG,Baker S Jr,Temin S,et al. American society of Clinical On- cology Clinical Practice Guideline update on chemotherapy for stage 1V non-small-cell lung cancer [ J ]. J Clin Oncol, 2009,27 ( 36 ) : 6251- 6266.
5Schiller JH, Harringto D, Belani CP, et al. Comparison of four chemo- therapy regimens for advanced non-small-cen lung cancer[ J]. N Engl J Med,2002,346(2) :92-98.
6Scagliotti GV, Kortsik C, Dark GG, et al. Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer a multicenter randomized, phase II trial [ J ] . Clin Cancer Res ,2005,11( 2Ptl ) :690-696.
7Zinner RG, Fossella FV, Gladish GW, et al. Phase II study of peme- trexed in combination with earboplatin in the first-line treatment of ad- all cell lung cancer [ J ]. C ,2005,104 ( 11 ) : 2449-2456.
